Rosiglitazone + Glimepiride - Antidiabetic Combination Products
Drug Name:
Rosiglitazone + Glimepiride - Antidiabetic Combination Products
List Of Brands:
Indication Type Description:
Indication:
Type II Diabetes not responsive to diet
Dosages/ Overdosage Etc:
Indication-
Type II Diabetes not responsive to diet
Dosage-
Maximum daily dose - rosiglitazone 8mg/glimepride 4mg per day.
Initial dosage- rosiglitazone 4mg/glimepride 1mg administered once daily with the first meal
of the day.
For patients already treated with sulfonylurea of thiazolidinedione a starting dose of 4mg/2mg
may be considered